Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer

Cancer
Lung Cancer
Small Cell Lung Cancer
Small Cell Lung Carcinoma

Results
Download
Print

Study results

LPS ML42391 MATCH Final Results April 2025 English (PDF, 0.4 MB)

LPS ML42391 MATCH Final Results April 2025 Chinese (PDF, 0.4 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer

Study results

LPS ML42391 MATCH Final Results April 2025 English (PDF, 0.4 MB)

LPS ML42391 MATCH Final Results April 2025 Chinese (PDF, 0.4 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer

For the latest version of this information please go to www.forpatients.roche.com